MedPath

Swansea University

Swansea University logo
🇬🇧United Kingdom
Ownership
Private
Established
1920-01-01
Employees
1K
Market Cap
-
Website
http://www.swan.ac.uk

Clinical Trials

53

Active:3
Completed:39

Trial Phases

3 Phases

Phase 1:2
Phase 4:1
Not Applicable:39

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (43 trials with phase data)• Click on a phase to view related trials

Not Applicable
39 (90.7%)
Phase 1
2 (4.7%)
phase_1_2
1 (2.3%)
Phase 4
1 (2.3%)

Patient Evaluation of Treatment of Pelvic-floor Muscle Dysfunction.

Not yet recruiting
Conditions
Pelvic-floor Disorders
First Posted Date
2025-05-08
Last Posted Date
2025-05-09
Lead Sponsor
Swansea University
Target Recruit Count
700
Registration Number
NCT06961513
Locations
🇬🇧

Singleton Hospital, Swansea, United Kingdom

Symptom-specific Effects of Omega-3 Across Neurodevelopmental Symptoms

Not Applicable
Recruiting
Conditions
Sleep
Autism or Autistic Traits
ADHD or ADHD Traits
First Posted Date
2024-11-21
Last Posted Date
2024-11-21
Lead Sponsor
Swansea University
Target Recruit Count
200
Registration Number
NCT06698588
Locations
🇬🇧

FHMLS, Swansea, United Kingdom

Optimizing Older Adults' Home Space for Physical Activity

Not Applicable
Completed
Conditions
Activity
First Posted Date
2024-05-09
Last Posted Date
2024-05-09
Lead Sponsor
Swansea University
Target Recruit Count
23
Registration Number
NCT06407557
Locations
🇬🇧

Swansea University, Swansea, United Kingdom

Isometric Handgrip Training Frequency and Blood Pressure in People With Hypertension

Not Applicable
Recruiting
Conditions
Hypertension
First Posted Date
2024-03-28
Last Posted Date
2024-03-28
Lead Sponsor
Swansea University
Target Recruit Count
45
Registration Number
NCT06335433
Locations
🇬🇧

Swansea University, Swansea, Wales, United Kingdom

The Dose Response Effect of Isometric Handgrip Training Frequency on Blood Pressure in Normotensive Individuals

Not Applicable
Completed
Conditions
Blood Pressure
First Posted Date
2024-03-26
Last Posted Date
2024-12-03
Lead Sponsor
Swansea University
Target Recruit Count
60
Registration Number
NCT06329804
Locations
🇨🇳

National Taiwan Normal University, Taipei, Taiwan

🇬🇧

Swansea University, Swansea, United Kingdom

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 8
  • Next

News

Psoriasis Drug Ustekinumab Shows Promise in Preserving Insulin Production in Young Type 1 Diabetes Patients

A clinical trial found that ustekinumab, a drug currently used for psoriasis, preserved insulin production in young type 1 diabetes patients, with C-peptide levels 49% higher after one year compared to placebo.

© Copyright 2025. All Rights Reserved by MedPath